Intraductal neoplasms of the pancreas

Seminars in Diagnostic Pathology

Volumn 31, Issue 6, 2014, Pages 452-466

  Klöppel, Günter ^a   Basturk, Olca ^b   Schlitter, Anna Melissa ^a   Konukiewitz, Björn ^a   Esposito, Irene ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Genetics; Intraductal papillary mucinous neoplasm; Intraductal tubulopapillary neoplasm; Pancreatic intraductal tumor; Prognosis

Indexed keywords

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CLINICAL FEATURE; CYST FLUID; DIFFERENTIAL DIAGNOSIS; DYSPLASIA; GENE; GENE MUTATION; GENE SEQUENCE; GNAS GENE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INTRADUCTAL TUBULAR PYLORIC GLAND TYPE ADENOMA; INTRADUCTAL TUBULOPAPILLARY CANCER; ONCOGENE K RAS; OUTCOME ASSESSMENT; PANCREAS CANCER; RNF43 GENE; TUMOR INVASION; ADENOMA; COLLOID CARCINOMA; PANCREAS CARCINOMA; PANCREAS TUMOR; PAPILLARY CARCINOMA; PATHOLOGY;

ADENOCARCINOMA, MUCINOUS; ADENOMA; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; HUMANS; PANCREATIC NEOPLASMS;

EID: 84916628437     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2014.08.005     Document Type: Article

References (190)

1. Adsay N.V., Klöppel G., Fukushima N., et al. Intraductal neoplasms of the pancreas. WHO Classification of Tumors 2010, 304-313. WHO Press, Lyon. F.T. Bosman, F. Carneiro, R.H. Hruban (Eds.).
2. Kim H.J., Kim Y.K., Jang K.T., et al. Intraductal growing acinar cell carcinoma of the pancreas. Abdom Imaging 2013, 38:1115-1119.
3. Basturk O., Zamboni G., Klimstra D.S., et al. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms. Am J Surg Pathol 2007, 31:363-370.
4. Chetty R., El-Shinnawy I. Intraductal pancreatic neuroendocrine tumor. Endocr Pathol 2009, 20:262-266.
5. Okazaki M., Makino I., Kitagawa H., et al. A case report of anaplastic carcinoma of the pancreas with remarkable intraductal tumor growth into the main pancreatic duct. World J Gastroenterol 2014, 20:852-856.
6. Tanaka M., Fernandez-del Castillo C., Adsay V., et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012, 12:183-197.
7. Tanaka M., Chari S., Adsay V., et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006, 6:17-32.
8. Hruban R.H., Takaori K., Klimstra D.S., et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004, 28:977-987.
9. Klöppel G, Solcia E, Longnecker DS. In: Hamilton SR, Aaltonen LA, eds., Histological typing of tumours of the exocrine pancreas. World Health Organization international histological classification of tumours. 2nd ed. New York: Springer-Verlag 1996.
10. Morohoshi T., Kanda M., Asanuma K., Capella C., Sobin L.H. Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients. Cancer 1989, 64:1329-1335.
11. Yanagisawa A., Ohashi K., Hori M., et al. Ductectatic-type mucinous cystadenoma and cystadenocarcinoma of the human pancreas: a novel clinicopathological entity. Jpn J Cancer Res 1993, 84:474-479.
12. Itai Y., Ohhashi K., Nagai H., et al. "Ductectatic" mucinous cystadenoma and cystadenocarcinoma of the pancreas. Radiology 1986, 161:697-700.
13. Yamada M., Kozuka S., Yamao K., et al. Mucin-producing tumor of the pancreas. Cancer 1991, 68:159-168.
14. Yamaguchi K., Tanaka M. Mucin-hypersecreting tumor of the pancreas with mucin extrusion through an enlarged papilla. Am J Gastroenterol 1991, 86:835-839.
15. Payan M.J., Xerri L., Moncada K., et al. Villous adenoma of the main pancreatic duct: a potentially malignant tumor?. Am J Gastroenterol 1990, 85:459-463.
16. Sahani D.V., Kadavigere R., Blake M., et al. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations-correlation with MRCP. Radiology 2006, 238:560-569.
17. Bernard P., Scoazec J.Y., Joubert M., et al. Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases. Arch Surg 2002, 137:1274-1278.
18. Terris B., Ponsot P., Paye F., et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000, 24:1372-1377.
19. Kobari M., Egawa S., Shibuya K., et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 1999, 134:1131-1136.
20. Hruban R., Pitman M.B., Klimstra D.S. Tumors of the pancreas. AFIP Atlas of Tumor Pathology 2007, American Registry of Pathology, Washington, DC.
21. Ban S., Naitoh Y., Mino-Kenudson M., et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol 2006, 30:1561-1569.
22. Furukawa T., Klöppel G., Volkan A.N., et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005, 447:794-799.
23. Adsay N.V., Merati K., Basturk O., et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004, 28:839-848.
24. Adsay N.V., Longnecker D.S., Klimstra D.S. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms. Semin Diagn Pathol 2000, 17:16-30.
25. Jyotheeswaran S., Zotalis G., Penmetsa P., et al. A newly recognized entity: intraductal "oncocytic" papillary neoplasm of the pancreas. Am J Gastroenterol 1998, 93:2539-2543.
26. Adsay N.V., Adair C.F., Heffess C.S., Klimstra D.S. Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol 1996, 20:980-994.
27. Valsangkar N.P., Morales-Oyarvide V., Thayer S.P., et al. 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery 2012, 152:S4-S12.
28. Klibansky D.A., Reid-Lombardo K.M., Gordon S.R., Gardner T.B. The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol 2012, 10:555-558.
29. Winter J.M., Cameron J.L., Lillemoe K.D., et al. Periampullary and pancreatic incidentaloma: a single institution[U+05F3]s experience with an increasingly common diagnosis. Ann Surg 2006, 243:673-680. [discussion 680-673].
30. Laffan T.A., Horton K.M., Klein A.P., et al. Prevalence of unsuspected pancreatic cysts on MDCT. Am J Roentgenol 2008, 191:802-807.
31. Lee K.S., Sekhar A., Rofsky N.M., et al. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol 2010, 105:2079-2084.
32. Ingkakul T., Warshaw A.L., Fernandez-Del Castillo C. Epidemiology of intraductal papillary mucinous neoplasms of the pancreas: sex differences between 3 geographic regions. Pancreas 2011, 40:779-780.
33. Fernandez-del Castillo C., Adsay N.V. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 2010, 139:708-713. [713 e701-702].
34. Ferrone C.R., Correa-Gallego C., Warshaw A.L., et al. Current trends in pancreatic cystic neoplasms. Arch Surg 2009, 144:448-454.
35. Salvia R., Fernandez-del Castillo C., Bassi C., et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004, 239:678-685. [discussion 685-677].
36. Sohn T.A., Yeo C.J., Cameron J.L., et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004, 239:788-797. [discussion 797-789].
37. Klöppel G. Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas. Hepatogastroenterology 1998, 45:1981-1985.
38. Traverso L.W., Peralta E.A., Ryan J.A., et al. Intraductal neoplasms of the pancreas. Am J Surg 1998, 175:426-432.
39. Jang J.W., Kim M.H., Jeong S.U., et al. Clinical characteristics of intraductal papillary mucinous neoplasm manifesting as acute pancreatitis or acute recurrent pancreatitis. J Gastroenterol Hepatol 2013, 28:731-738.
40. Capurso G., Boccia S., Salvia R., et al. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study. Am J Gastroenterol 2013, 108:1003-1009.
41. Larghi A., Panic N., Capurso G., et al. Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Oncol 2013, 24:1907-1911.
42. Reid-Lombardo K.M., Mathis K.L., Wood C.M., et al. Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasm of the pancreas: implications for management. Ann Surg 2010, 251:64-69.
43. Baumgaertner I., Corcos O., Couvelard A., et al. Prevalence of extrapancreatic cancers in patients with histologically proven intraductal papillary mucinous neoplasms of the pancreas: a case-control study. Am J Gastroenterol 2008, 103:2878-2882.
44. Eguchi H., Ishikawa O., Ohigashi H., et al. Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development. Surgery 2006, 139:749-754.
45. Kamisawa T., Tu Y., Egawa N., et al. Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas. World J Gastroenterol 2005, 11:5688-5690.
46. Sugiyama M., Atomi Y. Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 1999, 94:470-473.
47. Kim K.W., Park S.H., Pyo J., et al. Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Ann Surg 2014, 259:72-81.
48. Shimizu Y., Yamaue H., Maguchi H., et al. Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: analysis of 310 pancreatic resection patients at multiple high-volume centers. Pancreas 2013, 42:883-888.
49. Tanaka M., Sawai H., Okada Y., et al. Clinicopathologic study of intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas. Hepatogastroenterology 2006, 53:783-787.
50. Jang J.Y., Kim S.W., Ahn Y.J., et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery?. Ann Surg Oncol 2005, 12:124-132.
51. Ogawa H., Itoh S., Ikeda M., et al. Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT. Radiology 2008, 248:876-886.
52. Adsay N.V. Cystic lesions of the pancreas. Mod Pathol 2007, 20(suppl 1):S71-S93.
53. Fujii T., Ishikawa T., Kanazumi N., et al. Analysis of clinicopathological features and predictors of malignancy in intraductal papillary mucinous neoplasms of the pancreas. Hepatogastroenterology 2007, 54:272-277.
54. Gourgiotis S., Ridolfini M.P., Germanos S. Intraductal papillary mucinous neoplasms of the pancreas. Eur J Surg Oncol 2007, 33:678-684.
55. Raut C.P., Cleary K.R., Staerkel G.A., et al. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol 2006, 13:582-594.
56. Shimada K., Sakamoto Y., Sano T., et al. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma. Pancreas 2006, 32:281-287.
57. Lee S.Y., Lee K.T., Lee J.K., et al. Long-term follow up results of intraductal papillary mucinous tumors of pancreas. J Gastroenterol Hepatol 2005, 20:1379-1384.
58. Kosmahl M., Pauser U., Peters K., et al. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch 2004, 445:168-178.
59. Adsay N.V., Conlon K.C., Zee S.Y., et al. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer 2002, 94:62-77.
60. Longnecker D.S., Adler G., Hruban R.H., et al. Intraductal papillary-mucinous neoplasms of the pancreas. Tumors of the Exocrine Pancreas. Pathology and Genetics of Tumours of the Digestive System 2000, 237-240. IARC Press, Lyon. S.R. Hamilton, L.A. Aaltonen (Eds.).
61. Suzuki Y., Atomi Y., Sugiyama M., et al. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 2004, 28:241-246.
62. Nakagohri T., Kenmochi T., Kainuma O., et al. Intraductal papillary mucinous tumors of the pancreas. Am J Surg 1999, 178:344-347.
63. Paal E., Thompson L.D., Przygodzki R.M., et al. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature. Mod Pathol 1999, 12:518-528.
64. Sessa F., Solcia E., Capella C., et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994, 425:357-367.
65. Sipos B., Frank S., Gress T., Hahn S., Klöppel G. Pancreatic intraepithelial neoplasia revisited and updated. Pancreatology 2009, 9:45-54.
66. Kimura W., Nagai H., Kuroda A., et al. Analysis of small cystic lesions of the pancreas. Int J Pancreatol 1995, 18:197-206.
67. Brune K., Abe T., Canto M., et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 2006, 30:1067-1076.
68. Bartsch D.K., Dietzel K., Bargello M., et al. Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia?. Fam Cancer 2013, 12:89-96.
69. Nagasaka T., Nakashima N. Problems in histological diagnosis of intraductal papillary-mucinous tumor (IPMT). Hepatogastroenterology 2001, 48:972-976.
70. Terada T., Ohta T., Kitamura Y., et al. Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study. Arch Pathol Lab Med 1998, 122:42-46.
71. Terada T., Ohta T., Nakanuma Y. Expression of oncogene products, anti-oncogene products and oncofetal antigens in intraductal papillary-mucinous neoplasm of the pancreas. Histopathology 1996, 29:355-361.
72. Nagai E., Ueki T., Chijiiwa K., et al. Intraductal papillary mucinous neoplasms of the pancreas associated with so-called "mucinous ductal ectasia". Histochemical and immunohistochemical analysis of 29 cases. Am J Surg Pathol 1995, 19:576-589.
73. Furukawa T., Fujisaki R., Yoshida Y., et al. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas. Mod Pathol 2005, 18:1034-1042.
74. Iacobuzio-Donahue C.A., Wilentz R.E., Argani P., et al. Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Am J Surg Pathol 2000, 24:1544-1548.
75. Iacobuzio-Donahue C.A., Klimstra D.S., Adsay N.V., et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol 2000, 157:755-761.
76. Biankin A.V., Biankin S.A., Kench J.G., et al. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut 2002, 50:861-868.
77. Inoue H., Furukawa T., Sunamura M., et al. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis. Genes Chromosomes Cancer 2001, 31:295-299.
78. Lüttges J., Zamboni G., Longnecker D., Klöppel G. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001, 25:942-948.
79. Moore P.S., Sipos B., Orlandini S., et al. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch 2001, 439:798-802.
80. Satoh K., Sasano H., Shimosegawa T., et al. An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas. Cancer 1993, 72:51-56.
81. Terada T., Ohta T., Kitamura Y., et al. Endocrine cells in intraductal papillary-mucinous neoplasms of the pancreas. A histochemical and immunohistochemical study. Virchows Arch 1997, 431:31-36.
82. Adsay N.V., Merati K., Andea A., et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 2002, 15:1087-1095.
83. Nakamura A., Horinouchi M., Goto M., et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. J Pathol 2002, 197:201-210.
84. Yonezawa S., Sueyoshi K., Nomoto M., et al. MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients. Hum Pathol 1997, 28:344-352.
85. Ishida M., Egawa S., Aoki T., et al. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Pancreas 2007, 35:348-352.
86. Yonezawa S., Taira M., Osako M., et al. MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int 1998, 48:319-322.
87. Terris B., Dubois S., Buisine M.P., et al. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions. J Pathol 2002, 197:632-637.
88. Chung S.M., Hruban R.H., Iacobuzio-Donahue C.A. Analysis of molecular alterations and differentiation pathways in intraductal oncocytic papillary neoplasm of the pancreas. Mod Pathol 2005, 18:277A.
89. Basturk O., Khayyata S., Klimstra D.S., et al. Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis. Am J Surg Pathol 2010, 34:364-370.
90. Terris B., Blaveri E., Crnogorac-Jurcevic T., et al. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol 2002, 160:1745-1754.
91. Kitazono I., Higashi M., Kitamoto S., et al. Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas. Pancreas 2013, 42:1120-1128.
92. Mukawa K., Kawa S., Aoki Y., et al. Reduced expression of p53 and cyclin A in intraductal mucin-hypersecreting neoplasm of the pancreas compared with usual pancreatic ductal adenocarcinoma. Am J Gastroenterol 1999, 94:2263-2267.
93. Tomaszewska R., Okon K., Nowak K., et al. HER-2/Neu expression as a progression marker in pancreatic intraepithelial neoplasia. Pol J Pathol 1998, 49:83-92.
94. Yonaiyama S., Toyoki Y., Morohashi S., et al. Epithelial cell adhesion molecule (EpCAM) overexpression is correlated with malignant potentials of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. Biomed Res 2013, 34:87-95.
95. Hara T., Ikebe D., Odaka A., et al. Preoperative histological subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain. Ann Surg 2013, 257:1103-1111.
96. Cone M.M., Rea J.D., Diggs B.S., et al. Predicting malignant intraductal papillary mucinous neoplasm: a single-center review. Am J Surg 2011, 201:575-579.
97. Furukawa T., Hatori T., Fujita I., et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut 2011, 60:509-516.
98. Yamaguchi K., Kanemitsu S., Hatori T., et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas 2011, 40:571-580.
99. Schnelldorfer T., Sarr M.G., Nagorney D.M., et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg 2008, 143:639-646. [discussion 646].
100. Adsay N.V., Pierson C., Sarkar F., et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001, 25:26-42.
101. Seidel G., Zahurak M., Iacobuzio-Donahue C., et al. Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases. Am J Surg Pathol 2002, 26:56-63.
102. Adsay N.V., Merati K., Nassar H., et al. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol 2003, 27:571-578.
103. Lai E.C., Lau W.Y. Intraductal papillary mucinous neoplasms of the pancreas. Surgeon 2005, 3:317-324.
104. Falconi M., Salvia R., Bassi C., et al. Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg 2001, 88:376-381.
105. Mino-Kenudson M., Fernandez-del Castillo C., Baba Y., et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 2011, 60:1712-1720.
106. Yopp A.C., Katabi N., Janakos M., et al. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. Ann Surg 2011, 253:968-974.
107. Nakata K., Ohuchida K., Aishima S., et al. Invasive carcinoma derived from intestinal-type intraductal papillary mucinous neoplasm is associated with minimal invasion, colloid carcinoma, and less invasive behavior, leading to a better prognosis. Pancreas 2011, 40:581-587.
108. Sadakari Y., Ohuchida K., Nakata K., et al. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery 2010, 147:812-817.
109. Distler M., Kersting S., Niedergethmann M., et al. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg 2013, 258:324-330.
110. Adsay V., Basturk O., Saka B., et al. Whipple made simple for surgical pathologists: orientation, dissection and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct and ampullary tumors. Am J Surg Pathol 2014, 38:480-493.
111. Matthaei H., Norris A.L., Tsiatis A.C., et al. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2012, 255:326-333.
112. Ohtsuka T., Kono H., Tanabe R., et al. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg 2012, 204:44-48.
113. Sohn T.A., Yeo C.J., Cameron J.L., et al. Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg 2001, 234:313-321. [discussion 321-312].
114. Loftus E.V., Olivares-Pakzad B.A., Batts K.P., et al. Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the pancreas clinic, and pancreatic surgeons of Mayo clinic. Gastroenterology 1996, 110:1909-1918.
115. Patel S.A., Adams R., Goldstein M., et al. Genetic analysis of invasive carcinoma arising in intraductal oncocytic papillary neoplasm of the pancreas. Am J Surg Pathol 2002, 26:1071-1077.
116. Ideno N., Ohtsuka T., Kono H., et al. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg 2013, 258:141-151.
117. Yamaguchi K., Ohuchida J., Ohtsuka T., et al. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology 2002, 2:484-490.
118. Miyakawa S., Horiguchi A., Hayakawa M., et al. Intraductal papillary adenocarcinoma with mucin hypersecretion and coexistent invasive ductal carcinoma of the pancreas with apparent topographic separation. J Gastroenterol 1996, 31:889-893.
119. Komori T., Ishikawa O., Ohigashi H., et al. Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after resection of an intraductal papillary-mucinous carcinoma of the pancreatic head: a case report and comparison of DNA sequence in K-ras gene mutation. Jpn J Clin Oncol 2002, 32:146-151.
120. Fernandez-Esparrach G., Pellise M., Sole M., et al. EUS FNA in intraductal papillary mucinous tumors of the pancreas. Hepatogastroenterology 2007, 54:260-264.
121. Emerson R.E., Randolph M.L., Cramer H.M. Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of intraductal papillary mucinous neoplasm of the pancreas is highly predictive of pancreatic neoplasia. Diagn Cytopathol 2006, 34:457-462.
122. Layfield L.J., Cramer H. Fine-needle aspiration cytology of intraductal papillary-mucinous tumors: a retrospective analysis. Diagn Cytopathol 2005, 32:16-20.
123. Sole M., Iglesias C., Fernandez-Esparrach G., et al. Fine-needle aspiration cytology of intraductal papillary mucinous tumors of the pancreas. Cancer 2005, 105:298-303.
124. Recine M., Kaw M., Evans D.B., et al. Fine-needle aspiration cytology of mucinous tumors of the pancreas. Cancer 2004, 102:92-99.
125. Stelow E.B., Stanley M.W., Bardales R.H., et al. Intraductal papillary-mucinous neoplasm of the pancreas. The findings and limitations of cytologic samples obtained by endoscopic ultrasound-guided fine-needle aspiration. Am J Clin Pathol 2003, 120:398-404.
126. Pitman M.B., Michaels P.J., Deshpande V., et al. Cytological and cyst fluid analysis of small (< or =3cm) branch duct intraductal papillary mucinous neoplasms adds value to patient management decisions. Pancreatology 2008, 8:277-284.
127. Stelow E.B., Shami V.M., Abbott T.E., et al. The use of fine needle aspiration cytology for the distinction of pancreatic mucinous neoplasia. Am J Clin Pathol 2008, 129:67-74.
128. Bardales R.H., Stelow E.B., Mallery S., et al. Review of endoscopic ultrasound-guided fine-needle aspiration cytology. Diagn Cytopathol 2006, 34:140-175.
129. Michaels P.J., Brachtel E.F., Bounds B.C., et al. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade. Cancer 2006, 108:163-173.
130. Frossard J.L., Amouyal P., Amouyal G., et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol 2003, 98:1516-1524.
131. Hirono S., Tani M., Kawai M., et al. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2012, 255:517-522.
132. Morris-Stiff G., Lentz G., Chalikonda S., et al. Pancreatic cyst aspiration analysis for cystic neoplasms: mucin or carcinoembryonic antigen-which is better?. Surgery 2010, 148:638-644. [discussion 644-635].
133. Nagula S., Kennedy T., Schattner M.A., et al. Evaluation of cyst fluid CEA analysis in the diagnosis of mucinous cysts of the pancreas. J Gastrointest Surg 2010, 14:1997-2003.
134. Brugge W.R., Lewandrowski K., Lee-Lewandrowski E., et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004, 126:1330-1336.
135. Cizginer S., Turner B.G., Bilge A.R., et al. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas 2011, 40:1024-1028.
136. Maker A.V., Katabi N., Gonen M., et al. Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg Oncol 2011, 18:199-206.
137. Yao F., Sun M., Dong M., et al. NPTX2 hypermethylation in pure pancreatic juice predicts pancreatic neoplasms. Am J Med Sci 2013, 346:175-180.
138. Matthaei H., Wylie D., Lloyd M.B., et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res 2012, 18:4713-4724.
139. Ryu J.K., Matthaei H., Dal Molin M., et al. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology 2011, 11:343-350.
140. Panarelli N.C., Chen Y.T., Zhou X.K., et al. MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma. Pancreas 2012, 41:685-690.
141. Kaino M., Kondoh S., Okita S., et al. Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumors. Pancreas 1999, 18:294-299.
142. Nikiforova M.N., Khalid A., Fasanella K.E., et al. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts. Mod Pathol 2013, 26:1478-1487.
143. Pitman M.B., Lewandrowski K., Shen J., et al. Pancreatic cysts: preoperative diagnosis and clinical management. Cancer Cytopathol 2010, 118:1-13.
144. Garud S.S., Willingham F.F. Molecular analysis of cyst fluid aspiration in the diagnosis and risk assessment of cystic lesions of the pancreas. Clin Transl Sci 2012, 5:102-107.
145. Layfield L.J., Ehya H., Filie A.C., et al. Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: the Papanicolaou Society of Cytopathology guidelines for pancreatobiliary cytology. Diagn Cytopathol 2014, 42:351-362.
146. Basturk O., Coban I., Adsay N.V. Pancreatic cysts: pathologic classification, differential diagnosis, and clinical implications. Arch Pathol Lab Med 2009, 133:423-438.
147. Yamaguchi H., Shimizu M., Ban S., et al. Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2009, 33:1164-1172.
148. Klimstra D.S., Adsay N.V., Dhall D., et al. Intraductal tubular carcinoma of the pancreas: clinicopathologic and immunohistochemical analysis of 18 cases. Mod Pathol 2007, 20:285A. [Abstract].
149. Tajiri T., Tate G., Inagaki T., et al. Intraductal tubular neoplasms of the pancreas: histogenesis and differentiation. Pancreas 2005, 30:115-121.
150. Kosmahl M., Egawa N., Schröder S., Carneiro F., Lüttges J., Klöppel G. Mucinous nonneoplastic cyst of the pancreas: a novel nonneoplastic cystic change?. Mod Pathol 2002, 15:154-158.
151. Krasinskas A., Oakley G.J., Bagci P., et al. Cystic mucinous duct lesion of the pancreas: a clinicopathologic analysis of 40 examples of a diagnostically challenging and terminologically controversial entity. Mod Pathol 2012, 25:445A. [Abstract].
152. Kenney B., Singh G., Salem R.R., et al. Pseudointraductal papillary mucinous neoplasia caused by microscopic periductal endocrine tumors of the pancreas: a report of 3 cases. Hum Pathol 2011, 42:1034-1041.
153. Del Chiaro M., Verbeke C., Salvia R., et al. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis 2013, 45:703-711.
154. Piciucchi M., Crippa S., Del Chiaro M., et al. Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. Dig Liver Dis 2013, 45:584-588.
155. Sahora K., Mino-Kenudson M., Brugge W., et al. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg 2013, 258:466-475.
156. Zhong N., Zhang L., Takahashi N., et al. Histologic and imaging features of mural nodules in mucinous pancreatic cysts. Clin Gastroenterol Hepatol 2012, 10:192-198. [198 e191-192].
157. Akita H., Takeda Y., Hoshino H., et al. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery. Am J Surg 2011, 202:214-219.
158. Sadakari Y., Ienaga J., Kobayashi K., et al. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas 2010, 39:232-236.
159. White R., D'Angelica M., Katabi N., et al. Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg 2007, 204:987-993. [discussion 993-985].
160. Irie H., Yoshimitsu K., Aibe H., et al. Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow-up study by magnetic resonance cholangiopancreatography. J Comput Assist Tomogr 2004, 28:117-122.
161. Kobayashi G. Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan pancreas society multicenter study. 2014; 43: 532-538.
162. Tanno S., Nakano Y., Nishikawa T., et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut 2008, 57:339-343.
163. Salvia R., Crippa S., Falconi M., et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate?. Gut 2007, 56:1086-1090.
164. Sugiyama M., Izumisato Y., Abe N., et al. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 2003, 90:1244-1249.
165. Crippa S., Fernandez-Del Castillo C., Salvia R., et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol 2010, 8:213-219.
166. Chari S.T., Yadav D., Smyrk T.C., et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002, 123:1500-1507. [In Process Citation].
167. Poultsides G.A., Reddy S., Cameron J.L., et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg 2010, 251:470-476.
168. Murakami Y., Uemura K., Sudo T., et al. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma. J Surg Oncol 2009, 100:13-18.
169. Koh Y.X., Chok A.Y., Zheng H.L., Tan C.S., Goh B.K. Systematic review and meta-analysis comparing the surgical outcomes of Invasive intraductal papillary mucinous neoplasms and conventional pancreatic ductal adenocarcinoma. Ann Surg Oncol 2014, 21:2782-2800.
170. D'Angelica M., Brennan M.F., Suriawinata A.A., et al. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 2004, 239:400-408.
171. Nara S., Shimada K., Kosuge T., et al. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol 2008, 32:243-255.
172. Esposito I., Bauer A., Hoheisel J.D., et al. Microcystic tubulopapillary carcinoma of the pancreas: a new tumor entity?. Virchows Arch 2004, 444:447-453.
173. Konigsrainer I., Glatzle J., Klöppel G., et al. Intraductal and cystic tubulopapillary adenocarcinoma of the pancreas-a possible variant of intraductal tubular carcinoma. Pancreas 2008, 36:92-95.
174. Chetty R., Serra S. Intraductal tubular adenoma (pyloric gland-type) of the pancreas: a reappraisal and possible relationship with gastric-type intraductal papillary mucinous neoplasm. Histopathology 2009, 55:270-276.
175. Reid M.D., Saka B., Balci S., et al. Molecular genetics of pancreatic neoplasms and their morphologic correlates: an update on recent advances and potential diagnostic applications. Am J Clin Pathol 2014, 141:168-180.
176. Wu J., Jiao Y., Dal Molin M., et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A 2011, 108:21188-21193.
177. Z'Graggen K., Rivera J.A., Compton C.C., et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 1997, 226:491-498. [discussion 498-500].
178. Furukawa T., Kuboki Y., Tanji E., et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 2011, 1:161.
179. Wu J., Matthaei H., Maitra A., et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 2011, 3:92ra66.
180. Xiao H.D., Yamaguchi H., Dias-Santagata D., et al. Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms. J Pathol 2011, 224:508-516.
181. Mohri D., Asaoka Y., Ijichi H., et al. Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression. J Gastroenterol 2012, 47:203-213.
182. Amato E., Molin M.D., Mafficini A., et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol 2014, 233:217-227.
183. Dal Molin M., Matthaei H., Wu J., et al. Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg Oncol 2013, 20:3802-3808.
184. Komatsu H., Tanji E., Sakata N., et al. A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes. PLoS One 2014, 9:e87875.
185. Almoguera C., Shibata D., Forrester K., et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988, 53:549-554.
186. Jiang X., Hao H.X., Growney J.D., et al. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A 2013, 110:12649-12654.
187. Garcia-Carracedo D., Turk A.T., Fine S.A., et al. Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res 2013, 19:6830-6841.
188. Schonleben F., Qiu W., Remotti H.E., et al. PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas. Langenbecks Arch Surg 2008, 393:289-296.
189. Yamaguchi H., Kuboki Y., Hatori T., et al. Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas. Am J Surg Pathol 2011, 35:1812-1817.
190. Yamaguchi H., Kuboki Y., Hatori T., et al. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant. J Pathol 2013, 231:335-341.